ArticleClinical case reports2026
Aggressive Prostatic Stromal Sarcoma Mimicking Benign Prostatic Enlargement in a Middle-Aged Man: A Case Report.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostatic stromal sarcoma is an exceptionally rare mesenchymal malignancy with aggressive behavior and poor prognosis. It often presents with nonspecific lower urinary tract symptoms, frequently mimicking benign prostatic hyperplasia. We report a 51-year-old man who presented with hematuria and long-standing obstructive urinary symptoms. Imaging revealed a massively enlarged prostate with a low prostate-specific antigen level. The findings strongly favored benign prostatic enlargement. Given the severity of bladder outlet obstruction and absence of overt radiologic malignancy, open retropubic prostatectomy was performed for presumed benign disease. Histopathological examination unexpectedly revealed prostatic stromal sarcoma, with immunohistochemistry negative for epithelial, lymphoid, and common stromal markers. Postoperative staging performed following histologic diagnosis demonstrated extensive locally advanced pelvic disease and distant pulmonary metastases within weeks of surgery. Despite surgical intervention, the patient rapidly developed locally advanced pelvic disease with pulmonary metastases and succumbed to the illness before initiation of palliative chemotherapy. This case underscores the diagnostic challenges, aggressive natural history, and limited therapeutic options for prostatic stromal sarcoma, particularly in low-resource settings, and emphasizes the need for heightened clinical suspicion and early multidisciplinary involvement when intraoperative findings are encountered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.